Subject: PZOO Issues Huge News PSID Interview Gives 2015 Outlook

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
PZOO Issues Huge News PSID Interview Gives 2015 Outlook
Hot Stock to WatchHot Stock to Watch

Company: Pazoo Inc. (OTCQB: PZOO)

End of Day:

Price: 0.0219

Change (%): + 0 (0.00)

Volume: 322,780
PZOO Chart

MA & Associates, LLC, Pazoo's Nevada Medical Marijuana Laboratory Testing Partner, Receives Purchase Order From One of the Largest Growers in Nevada

WHIPPANY, N.J., Dec. 11, 2014 (GLOBE NEWSWIRE) - Pazoo, Inc. (OTCQB:PZOO) (German WKN#: A1J3DK) is pleased to announce that its medical marijuana testing laboratory partner MA & Associates, LLC (MA) has received its first purchase order to test product from one of the largest growers in the State of Nevada. The first marijuana product to be tested is expected to be begin on or about the end of February 2015.

While this initial purchase order is for a few thousand dollars, it will serve as a quality test for our client. MA is 100% confident that we will not only meet but exceed the standards our clients expect. This is the beginning of a very important relationship with one of the largest growers in the State of Nevada. This grower, which has requested its name remain confidential, will represent approximately 200,000 square feet of growing. MA’s management team has estimated that every 100,000 square feet of grow that is tested will translate into approximately 1,000,000 dollars of revenue per calendar year. To date, MA feels confident that it has forged working relationships with additional growers who will test through MA and who will represent approximately another 500,000 square feet of grow.

Continue Reading

Top PerformerYesterday's Top Performer

PositiveID Corporation (OTCQB: PSID)

End of Day:

Price: 0.0269

Change (%): + 0.0006 (2.28)

Volume: 1,991,430
PSID Chart

PositiveID Corporation Discusses Its Recent 4 Million Dollar Financing and Provides 2015 Outlook in New Interview With

AUSTIN, Texas, Dec. 11, 2014 (GLOBE NEWSWIRE) -, Inc. today announced it conducted a new audio interview with PositiveID Corporation (“PositiveID” or the “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions. In the interview, which can be heard at, PositiveID’s Chairman and CEO, William J. Caragol, discusses the Company’s recent 4 million dollar financing and provides PositiveID’s outlook for 2015.

Continue Reading

SmallCapVoice Clients' News

Medical Marijuana Inc. (Pink Sheets: MJNA)

Medical Marijuana, Inc.'s HempMeds Educates A4M Doctors on Anti-Aging Cannabis Products

Sponsored Lecture, Evening Networking and CME Credits on All-Natural Hemp Cannabidiol (CBD) Through A4M World Congress in Las Vegas

SAN DIEGO, Dec. 11, 2014 (GLOBE NEWSWIRE) - Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to inform shareholders and the general public that HempMeds™ - a corporate portfolio company of Medical Marijuana, Inc. - is dramatically expanding its brand presence though natural hemp cannabidiol (CBD) education at the American Academy of Anti-Aging Medicine (A4M) World Congress in Las Vegas, Dec. 11-13. The A4M global conference on anti-aging, regenerative and aesthetic medicine markets to more than 26,000 physicians and scientists from 120 countries.

At the A4M Las Vegas conference, Dr. James J. Bradstreet MD, MD(H), FAAFP, known for his collaboration on cannabinoid research, is conducting the CME lecture on Thursday, Dec. 11: Understanding the Pivotal Role of the Endocannabinoid System and Cannabinoid Ligands in Aging, Obesity, Heart Disease, Neurodegeneration and Pain. The A4M is also releasing a scholarly article on cannabinoids by Dr. Bradstreet at their 2014 Las Vegas World Congress.

Continue Reading

Other Small Cap News

Company: mCig, Inc. (OTCQB: MCIG)

mCig, Inc. & VitaCig, Inc. Launch First Retail Location at World Renowned Hollywood & Highland Mall Los Angeles

BEVERLY HILLS, Calif., Dec. 11, 2014 (GLOBE NEWSWIRE) -- mCig(R), Inc. (OTCQB:MCIG) ("mCig"), a technology company, is pleased to announce that the company together with its 47% owned affiliate VitaCig, Inc. will be launching a jointly operated retail outlet at the world renowned Dolby Theater (formerly known as the Kodak Theatre) located in the heart of Hollywood alongside the "Walk of Fame", at the Hollywood & Highland Mall. This high-traffic area draws nearly 18 million visitors per year and over 100,000 cars per day. The Dolby Theatre also hosts some of the most important red carpet events and galas including studio movie premieres, the Grammy's, and the Academy Awards (Oscars).

The specific location for the mCig/VitaCig store has been strategically placed directly in front view of the Hollywood sign where thousands line up everyday for photos of this world famous view. The retail location is directly in front of Starbucks, centered in the smoking section, and across from Lids sports shop, Victoria's Secret. The store will open for business tomorrow December 11, 2014.

Continue Reading

Company: Aristocrat Group Corp. (OTCBB: ASCC)

ASCC: IMEA Country Male Artist of the Year Curtis Braly Sets January Release Date for ‘Doors Closing Everywhere’ Single

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--Fast-rising country music recording artist Curtis Braly has announced a January 5 release date of “Doors Closing Everywhere,” the first single from his upcoming EP All About the Ride. Sponsored by the Aristocrat Group Corp. (OTCBB:ASCC) and its award-winning RWB Ultra-Premium Handcrafted Vodka, Braly was recently named the 2014 International Music and Entertainment Association’s Country Male Artist of the Year.

Produced by Grammy-winning Kenny Royster, “Doors Closing Everywhere” will be released to country radio December 15 and to fans of the number one music format in the U.S. on January 5. The All About the Ride EP, which will be available in February, has breakout expectations and includes a duet with Season 2 American Idol finalist Kimberly Caldwell.

Continue Reading

Market News

By Lucia Mutikani: Reuters

Solid U.S. retail sales point to brisk consumer spending

WASHINGTON (Reuters) - U.S. consumer spending advanced at a brisk clip in November as lower gasoline prices gave the holiday shopping season a boost, offering the latest sign of underlying momentum in the economy.

The Commerce Department said on Thursday retail sales excluding automobiles, gasoline, building materials and food services, increased 0.6 percent last month after rising 0.5 percent in October.

The so-called core retail sales correspond most closely with the consumer spending component of gross domestic product. November's increase exceeded Wall Street's expectations for a 0.4 percent gain.

Continue Reading

By Jeff Macke:
Yahoo Finance

Market slide setting up for Santa Claus rally

Bells are ringing all over Wall Street. The only question is whether it's a signal to sell or the sound of distant sleigh bells. Stock futures are marginally higher this morning as traders limp in to work after the worst day for stocks since October 9. Yesterday the Dow lost 268 points and the S&P 500 dropped 1.6%.

Why the weakness? I've been talking about it all week but by now it's obvious to just about everyone: It's the crude! Need me to draw you a picture? I've got two. First the 5 day chart for both crude and stocks. The S&P 500 down 2.4%, oil lower by 7.4%. Lock step. The other: The Philly Oil Service Index over the last six months has lost 33%.

There's all kinds of connect-the-dot reasons an uncontrolled drop in crude is bad for, say, tech stocks that don't seem to have anything to do with one another. Just hit some of the links in this piece if you missed our earlier conversations.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks